VERILUMA : Board Changes

2 August 2017 ASX Announcement Appointment and Resignation of Non-Executive Director

Veriluma Limited (ASX: VRI, Veriluma or Company) is pleased to announce the appointment of Mr John Welsh as Non-Executive Director.

Mr Welsh has extensive operational and investment banking experience. As a Board Director and business executive, he has experience across Fintech, Industrial, and Equity Capital Markets. He is a graduate of the Institute of Company Directors.

Veriluma also advises that Mr Henry Capra, Non-Executive Director, has given notice of his resignation from the Company, effective today. Mr Capra has indicated that his other business commitments have increased considerably in recent weeks and these require his immediate time and attention. Accordingly, he regrettably cannot fully commit to his role on the board until such time as these activities have reduced.

Commenting on his departure, Mr Henry Capra stated: "It is with great regret that I am stepping down from the Veriluma board today, due to increasing demands being placed on my time by my other business commitments. I remain a strong believer in Veriluma's prescriptive analytics software and continue to see a huge opportunity for the application of its technology across many market sectors. I will be following Veriluma's progress closely and wish it every future success."

Veriluma's Chairman, Mr Rick Anstey, said Henry in his short time with the board had played a key advisory role to the Company and on behalf of the Board we wish him all the best for the future.

For more information, please contact:

Investor Relations [e-mail]

[phone]

www.veriluma.com

About Veriluma and Prescriptive Analytics:

Veriluma has developed and patented an advanced algorithm dealing in Prescriptive Analytics. Prescriptive Analytics is a form of advanced, forward-looking analytics, which provides assessments about future outcomes. Although most types of analytics aim to assist and improve in the decision making process, only Prescriptive Analytics delivers a preferred course of action. Developed by a Commonwealth Research Centre for the Australian Defence Intelligence Organisation, which has been utilising Veriluma's technology since 2013, Veriluma's software assists decision makers with rapid and accurate assessments of terrorism and national securit y threats using its proprietary technology based on Prescriptive Analytics.

In complex decision making situations, the ability to comprehensively manage incomplete or uncertain inputs is highly valuable for businesses, governments and individuals. ¹The Prescriptive Analytics software market is expected to reach US$1.1 billion in the next 3 years, with a 22% Compound Annual Growth Rate (CAGR) from 2016. Currently, 10% of organisations have some form of prescriptive analytics and this is expected to grow to 35% by 2020. ¹Source: Gartner Forecast Snapshot: Prescriptive Analytics, Worldwide, 2016; 5 February 2016

Veriluma's software has wide applications across multiple industries including banking and financial services, government, defence and national security, insurance, legal, health, pharmaceutical and resources.